NEU neuren pharmaceuticals limited

Fragile X, page-9

  1. 7,795 Posts.
    lightbulb Created with Sketch. 907
    Just a reminder that FXCRC sites are participating in Neuren's Fragile X trials. I'm guessing Neuren's trial may get a mention. If we are lucky.

    "Neuren Pharmaceuticals (NEU) has received approval from the US Food and Drug Administration to conduct a Phase 2 clinical trial of a drug to treat patients with fragile X syndrome (FXS), the company recently announced. The trial is expected to start before the end of 2013, and is expected to involve several sites within the Fragile X Clinical & Research Consortium (FXCRC). - See more at: http://www.fragilex.org/2013/resear...-for-fragile-x-syndrome/#sthash.mQWV3nzc.dpuf"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.48
Change
-0.110(0.75%)
Mkt cap ! $1.773B
Open High Low Value Volume
$14.36 $14.51 $14.25 $1.004M 69.99K

Buyers (Bids)

No. Vol. Price($)
2 30 $14.48
 

Sellers (Offers)

Price($) Vol. No.
$14.51 201 3
View Market Depth
Last trade - 11.17am 16/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.